|
|
Policy Programme
Reacting to concerns that international drug policy debates are insufficiently
informed by the growing evidence base, the Beckley Foundation directs
a programme of research and policy analysis. In spite of 40 years of prohibition, drugs are cheaper, purer and more widely avaialble than ever before.
The Beckley Foundation Drug Policy Programme (BFDPP) was set up to develop a scientifically-evaluated evidence base, and provide a rigorous, independent review of current global drug policy. It aims to cast light on the current dilemmas facing policymakers within governments and international agencies, and to work with them in order to promote objective and open debate on the effectiveness, direction and content of future drug policies.
The Policy Programme supports evidence-based policies that are effective in reducing drug related-harms, whilst also respecting individual freedoms.
The initiative consists of a number of interlinked components:
The BFDPP is directed by Amanda
Feilding, director of the Beckley Foundation, and Mike
Trace, an independent consultant, who has previously worked as an
advisor on the misuse of drugs to the British government, European Union
and United Nations.
The Beckley Foundation Drug Policy Programme is funded
by several philanthropic organisations, which share our principles
and objectives. Our main sponsors are the Getty Foundation (http://www.getty.edu/foundation/),
which is a constituent of the J. Paul Getty Trust (http://www.getty.edu/);
the San Francisco Foundation (http://www.sff.org/); the Open Society
Institute (OSI)(http://www.soros.org/); and the Beckley Foundation (http://www.beckleyfoundation.org/).These are research-oriented organisations committed to improving understanding of social problems and promoting possible policy solutions. We also enjoy and greatly appreciate the support given to the Foundation by a number of private individuals.
Recomended Books for further reading:
Drug War Heresies: Learning from Other Vices, Times, and Places (Rand Studies in Policy Analysis)
Drug Crazy: How We Got Into This Mess and How We Can Get Out
Our Right to Drugs: The Case for a Free Market
|